These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
283 related articles for article (PubMed ID: 35654711)
1. Platelet and extracellular vesicles in COVID-19 infection and its vaccines. Goubran H; Seghatchian J; Sabry W; Ragab G; Burnouf T Transfus Apher Sci; 2022 Jun; 61(3):103459. PubMed ID: 35654711 [TBL] [Abstract][Full Text] [Related]
2. Platelet extracellular vesicles in COVID-19: Potential markers and makers. Puhm F; Flamand L; Boilard E J Leukoc Biol; 2022 Jan; 111(1):63-74. PubMed ID: 34730839 [TBL] [Abstract][Full Text] [Related]
3. SARS-CoV-2 primed platelets-derived microRNAs enhance NETs formation by extracellular vesicle transmission and TLR7/8 activation. Liao TL; Liu HJ; Chen DY; Tang KT; Chen YM; Liu PY Cell Commun Signal; 2023 Oct; 21(1):304. PubMed ID: 37904132 [TBL] [Abstract][Full Text] [Related]
4. Role of neutrophils, platelets, and extracellular vesicles and their interactions in COVID-19-associated thrombopathy. Caillon A; Trimaille A; Favre J; Jesel L; Morel O; Kauffenstein G J Thromb Haemost; 2022 Jan; 20(1):17-31. PubMed ID: 34672094 [TBL] [Abstract][Full Text] [Related]
5. Platelet-released extracellular vesicles: the effects of thrombin activation. Suades R; Padró T; Vilahur G; Badimon L Cell Mol Life Sci; 2022 Mar; 79(3):190. PubMed ID: 35288766 [TBL] [Abstract][Full Text] [Related]
6. Platelet-derived- Extracellular Vesicles Promote Hemostasis and Prevent the Development of Hemorrhagic Shock. Lopez E; Srivastava AK; Burchfield J; Wang YW; Cardenas JC; Togarrati PP; Miyazawa B; Gonzalez E; Holcomb JB; Pati S; Wade CE Sci Rep; 2019 Nov; 9(1):17676. PubMed ID: 31776369 [TBL] [Abstract][Full Text] [Related]
7. Platelet-derived extracellular vesicles released after trauma promote hemostasis and contribute to DVT in mice. Dyer MR; Alexander W; Hassoune A; Chen Q; Brzoska T; Alvikas J; Liu Y; Haldeman S; Plautz W; Loughran P; Li H; Boone B; Sadovsky Y; Sundd P; Zuckerbraun BS; Neal MD J Thromb Haemost; 2019 Oct; 17(10):1733-1745. PubMed ID: 31294514 [TBL] [Abstract][Full Text] [Related]
8. Platelets Extracellular Vesicles as Regulators of Cancer Progression-An Updated Perspective. Żmigrodzka M; Witkowska-Piłaszewicz O; Winnicka A Int J Mol Sci; 2020 Jul; 21(15):. PubMed ID: 32707975 [TBL] [Abstract][Full Text] [Related]
9. Platelet-derived extracellular vesicles play an important role in platelet transfusion therapy. Cai Z; Feng J; Dong N; Zhou P; Huang Y; Zhang H Platelets; 2023 Dec; 34(1):2242708. PubMed ID: 37578045 [TBL] [Abstract][Full Text] [Related]
10. Platelet-derived extracellular vesicles for drug delivery. Yao C; Wang C Biomater Sci; 2023 Aug; 11(17):5758-5768. PubMed ID: 37489841 [TBL] [Abstract][Full Text] [Related]
11. P2Y12 antagonist ticagrelor inhibits the release of procoagulant extracellular vesicles from activated platelets. Gasecka A; Nieuwland R; van der Pol E; Hajji N; Ćwiek A; Pluta K; Konwerski M; Filipiak KJ Cardiol J; 2019; 26(6):782-789. PubMed ID: 29671861 [TBL] [Abstract][Full Text] [Related]
12. First-in-human clinical trial of allogeneic, platelet-derived extracellular vesicles as a potential therapeutic for delayed wound healing. Johnson J; Law SQK; Shojaee M; Hall AS; Bhuiyan S; Lim MBL; Silva A; Kong KJW; Schoppet M; Blyth C; Ranasinghe HN; Sejic N; Chuei MJ; Tatford OC; Cifuentes-Rius A; James PF; Tester A; Dixon I; Lichtfuss G J Extracell Vesicles; 2023 Jul; 12(7):e12332. PubMed ID: 37353884 [TBL] [Abstract][Full Text] [Related]
13. Platelets and extracellular vesicles in disease promotion via cellular cross-talk and eicosanoid biosynthesis. Contursi A; Tacconelli S; Di Berardino S; De Michele A; Patrignani P Prostaglandins Other Lipid Mediat; 2024 Aug; 173():106848. PubMed ID: 38723943 [TBL] [Abstract][Full Text] [Related]
14. The potential utilization of platelet-derived extracellular vesicles in clinical treatment. Fan Z; Gan Y; Hu Y Platelets; 2024 Dec; 35(1):2397592. PubMed ID: 39287127 [TBL] [Abstract][Full Text] [Related]
15. COVID-19 adenovirus vaccine triggers antibodies against PF4 complexes to activate complement and platelets. Pitkänen HH; Jouppila A; Helin T; Dulipati V; Kotimaa J; Meri S; Kantele A; Jalkanen P; Julkunen I; Lassila R Thromb Res; 2021 Dec; 208():129-137. PubMed ID: 34768097 [TBL] [Abstract][Full Text] [Related]
16. The Impact of Platelet Isolation Protocol on the Release of Extracellular Vesicles. Zarà M; Vismara M; Dona G; Trivigno SMG; Amadio P; Sandrini L; Guidetti GF; Barbieri SS Front Biosci (Landmark Ed); 2022 May; 27(5):161. PubMed ID: 35638428 [TBL] [Abstract][Full Text] [Related]
17. Differential effects of physiological agonists on the proteome of platelet-derived extracellular vesicles. Gutmann C; Mayr M Proteomics; 2024 Aug; 24(16):e2400090. PubMed ID: 39148210 [TBL] [Abstract][Full Text] [Related]